ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

EVOK Evoke Pharma Inc

0.4577
-0.0223 (-4.65%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Evoke Pharma Inc EVOK NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
-0.0223 -4.65% 0.4577 15:30:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.453 0.4104 0.55 0.4577 0.48
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
17/4/202407:30GLOBEEvoke Pharma to Host Virtual Key Opinion Leader (KOL)..
21/3/202415:15GLOBEEvoke Pharma Announces Senior Leadership Transition with..
14/3/202415:05GLOBEEvoke Pharma Reports Fourth Quarter and Full Year 2023..
07/3/202415:10GLOBEEvoke Pharma to Report Fourth Quarter and Full Year 2023..
23/2/202415:15EDGAR2Form 8-K - Current report
20/2/202415:38EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202408:00EDGAR2Form 8-K - Current report
14/2/202406:30GLOBEEvoke Pharma Announces Closing of $7.5 Million Public..
09/2/202416:15EDGAR2Form 8-K - Current report
09/2/202416:14EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
09/2/202406:30GLOBEEvoke Pharma Announces Pricing of Underwritten Public..
08/2/202423:15EDGAR2Form EFFECT - Notice of Effectiveness
08/2/202405:50EDGAR2Form S-1/A - General form for registration of securities..
10/1/202420:38EDGAR2Form S-1/A - General form for registration of securities..
04/1/202415:30EDGAR2Form S-1/A - General form for registration of securities..
19/12/202307:30EDGAR2Form S-1/A - General form for registration of securities..
15/12/202315:30EDGAR2Form S-1/A - General form for registration of securities..
29/11/202308:00EDGAR2Form 8-K - Current report
27/11/202315:30EDGAR2Form 8-K - Current report
27/11/202307:30GLOBEEvoke Pharma Announces FDA Orange Book Listing of New GIMOTI..
22/11/202315:15EDGAR2Form 8-K - Current report
14/11/202307:30GLOBEUnited States Patent and Trademark Office (USPTO) Grants..
09/11/202315:30EDGAR2Form S-1 - General form for registration of securities under..
09/11/202308:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202308:00EDGAR2Form 8-K - Current report
09/11/202307:30GLOBEEvoke Pharma Reports Third Quarter 2023 Financial Results
01/11/202307:30EDGAR2Form 8-K - Current report
31/10/202307:30GLOBEEvoke Pharma & EVERSANA Unveil Cost Savings Real-World Data..
18/10/202307:30GLOBEEvoke Pharma’s Abstract Entitled “Superiority of Nasal Spray..
12/10/202315:30EDGAR2Form 8-K - Current report
14/9/202307:30GLOBEEvoke Pharma Receives Notice of Allowance from USPTO for..
11/8/202308:01EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/8/202308:03EDGAR2Form 8-K - Current report
10/8/202308:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202307:30GLOBEEvoke Pharma Reports Second Quarter 2023 Financial Results
07/8/202307:30GLOBEEvoke Pharma and EVERSANA Announce Abstract Acceptance at..
25/7/202307:30GLOBEEvoke Pharma and EVERSANA Announce Abstract Selection for..
21/7/202308:00EDGAR2Form 8-K - Current report
14/6/202307:30GLOBEEvoke Pharma to Host First Key Opinion Leader Webinar on..
15/5/202315:05GLOBEEvoke Pharma Reports First Quarter 2023 Financial Results
09/5/202306:00GLOBEReal-World Data Presented by Evoke Pharma and EVERSANA at..
04/5/202307:30GLOBEEvoke Pharma’s Real-World Healthcare Utilization Data..

Su Consulta Reciente

Delayed Upgrade Clock